New ALS therapy

A research led by Washington University School of Medicine in St. Louis indicated an investigational therapy for an inherited form of amyotrophic lateral sclerosis (ALS).  The comparative research carried out on mice and rats proved to be successful on genetically the rodents with human SOD1 gene when compared to the anti-SOD1 oligo or placebo used in another set of mice/rats. The mice/rats that obtained SOD1 gene lived longer maintaining their weight for a longer period of time compared to the control group.

This paved a new path for ALS treatment as the current treatments present produces a slow response.